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1 |  INTRODUCTION
Urinary tract infection (UTI) affects millions of people 
worldwide, exerting substantial impact both economically 
and on quality of life. Uropathogenic Escherichia coli 
(UPEC) cause over 80% of UTIs, including acute and re-
current bladder infection (cystitis) and ascending infection 
of one or both kidneys (pyelonephritis). Epidemiologically, 
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Abstract
Renal scarring after pyelonephritis is linked to long-term health risks for hyperten-
sion and chronic kidney disease. Androgen exposure increases susceptibility to, and 
severity of, uropathogenic Escherichia coli (UPEC) pyelonephritis and resultant 
scarring in both male and female mice, while anti-androgen therapy is protective 
against severe urinary tract infection (UTI) in these models. This work employed 
androgenized female C57BL/6 mice to elucidate the molecular mechanisms of post-
infectious renal fibrosis and to determine how these pathways are altered by the pres-
ence of androgens. We found that elevated circulating testosterone levels primed the 
kidney for fibrosis by increasing local production of TGFβ1 before the initiation of 
UTI, altering the ratio of transcription factors Smad2 and Smad3 and increasing the 
presence of mesenchymal stem cell (MSC)-like cells and Gli1 + activated myofibro-
blasts, the cells primarily responsible for deposition of scar components. Increased 
production of TGFβ1 and aberrations in Smad2:Smad3 were maintained throughout 
the course of infection in the presence of androgen, correlating with renal scarring 
that was not observed in non-androgenized female mice. Pharmacologic inhibition of 
TGFβ1 signaling blunted myofibroblast activation. We conclude that renal fibrosis 
after pyelonephritis is exacerbated by the presence of androgens and involves acti-
vation of the TGFβ1 signaling cascade, leading to increases in cortical populations 
of MSC-like cells and the Gli1 + activated myofibroblasts that are responsible for 
scarring.
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UTI is primarily a disease of females; however, infant boys 
and elderly men exhibit higher rates of UTI compared to fe-
males of equivalent ages (Foxman, 2002; Foxman, Barlow, 
D’Arcy, Gillespie, & Sobel, 2000; Hummers-Pradier, Ohse, 
Koch, Heizmann, & Kochen, 2004; Ruben et al., 1995; 
Shaikh, Morone, Bost, & Farrell, 2008; Wettergren, Jodal, 
& Jonasson, 1985). Furthermore, complicated UTI in males 
carries increased morbidity and mortality compared to that of 
females (Foxman, 2002; Lipsky, 1989). In childhood, ~7% of 
febrile UTI episodes result in formation of renal scars (Shaikh 
et al., 2016), which correlate with elevated risk for hyperten-
sion, chronic kidney disease, and end-stage kidney disease 
later in life (Calderon-Margalit et al., 2018; Efstathiou et al., 
2003; Foxman, Klemstine, & Brown, 2003; Ki, Park, Choi, 
& Foxman, 2004; Nicolle, Friesen, Harding, & Roos, 1996; 
Ricardo et al., 2019).
Testosterone signaling through the androgen receptor in-
creases susceptibility to, and severity of, experimental UPEC 
pyelonephritis in both male and female mice (Olson, Hruska, 
& Hunstad, 2016), while anti-androgen therapy is protective 
against severe UTI in mice (Olson et al., 2017) and in women 
with polycystic ovary syndrome (Gamal, Elkholi, & Nagy, 
2016; Wang, Su, Liu, Chang, & Chen, 2005), a common hy-
perandrogenic condition. As observed in children, mice with 
severe pyelonephritis develop renal fibrosis and scarring 
(Olson et al., 2018). In non-infectious models of renal injury, 
fibrosis is caused by excess extracellular matrix (ECM) depo-
sition by α-smooth muscle actin (αSMA)-positive activated 
myofibroblasts. Just over half of activated myofibroblasts are 
derived from Gli1+ mesenchymal stem cell (MSC)-like cells 
that reside in the perivascular niche (Kramann, Fleig, et al., 
2015; Kramann, Schneider, et al., 2015). The remaining ac-
tivated myofibroblasts in the recently injured kidney may be 
derived from several different progenitor cell types including 
resident fibroblasts, epithelial cells, endothelial cells, or pre-
cursors recruited from the bone marrow (Chen et al., 2011; 
Iwano et al., 2002; Ng et al., 1998; Piera-Velazquez, Li, & 
Jimenez, 2011; Reich et al., 2013; Schnaper, Hayashida, 
Hubchak, & Poncelet, 2003; Wu et al., 2013; Xavier et al., 
2015). However, activated myofibroblasts can lose their pro-
genitor cell type-specific markers during transition, making 
it challenging to definitively determine their cell lineage 
(Humphreys, 2018).
Activated myofibroblasts are highly sensitive to TGFβ1 
signaling, the production of which is known to be upregu-
lated following experimental non-infectious renal injury 
(Gentle et al., 2013; Loeffler & Wolf, 2014). Ligation of the 
TGFβ1 receptor leads to phosphorylation of the transcription 
factors Smad2 and Smad3, which then complex with Smad4 
and translocate into the nucleus, upregulating transcription 
of αSMA and ECM components such as collagens I and III 
(Hill, 2009; Inman, Nicolás, & Hill, 2002). Other TGFβ su-
perfamily members (e.g., activin A), as well as members of 
the Hedgehog signaling cascade (e.g., Gli1), can also signal 
through Smad transcription factors using nonredundant re-
ceptors and pathways (Agapova, Fang, Sugatani, Seifert, 
& Hruska, 2016; Kramann, 2016; Yamashita, Maeshima, 
Kojima, & Nojima, 2004; Zhang, Tian, & Xing, 2016). Under 
normal conditions, a renal insult subsides and the secreted 
ECM is subsequently degraded by locally generated colla-
genases (Bauman et al., 2010; Wang et al., 2006; Zeisberg 
et al., 2003), enabling productive healing and regeneration of 
functional tubules in the affected area of kidney. Aberrations 
in this signaling cascade, or more severe or prolonged injury, 
may push fibrotic signaling beyond the point of no return, 
precluding productive repair and resulting in permanent scar-
ring (Genovese, Manresa, Leeming, Karsdal, & Boor, 2014).
We recently developed a preclinical model in which ex-
perimental pyelonephritis (even when successfully treated 
with clinically relevant antibiotics) results in scar formation 
in C3H mice, a strain featuring vesicoureteral reflux (Olson 
et al., 2017). Here, we extended these models into non-re-
fluxing C57BL/6 mice, which when androgenized are per-
missive for pyelonephritis, but without the abscess formation 
seen in C3H mice (Olson et al., 2018). This system allowed 
us to interrogate the molecular mechanisms of renal fibrosis, 
separate from the severity of UTI per se, and to specify how 
the activity of these pathways is enhanced in the presence of 
androgens.
2 |  METHODS
2.1 | Bacterial strains
Uropathogenic Escherichia coli (UPEC) strain UTI89, a 
clinical cystitis isolate (Chen et al., 2009), was grown in 
Luria-Bertani (LB; Becton Dickinson [BD]) broth statically 
overnight at 37°C. Cultures were centrifuged for 10 min at 
7,500g at 4°C before being resuspended in sterile phosphate-
buffered saline (PBS) to a density of ~4 × 108 colony-form-
ing units (CFU)/ml.
2.2 | Animals
All animal protocols received prior approval from the 
Washington University Institutional Animal Care and Use 
Committee. Experiments were conducted in C57BL/6 mice 
(#000664; Jackson Laboratories) or, for immunofluores-
cence studies, in bigenic Gli1-tdTomato+ mice harboring 
a tamoxifen-inducible Cre that enables tdTomato produc-
tion from the Gli1 promoter (kind gift of B. Humphreys; 
(Kramann, Schneider, et al., 2015)). For androgenization, 
female mice of either strain were administered testoster-
one cypionate (TC; Depo-Testosterone, Pfizer) 150  mg/
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kg IM weekly beginning at 5 weeks of age and continuing 
until sacrifice. UTI was initiated by bladder inoculation 
with 1–2 × 107 CFU of UPEC via catheter at 7 weeks of 
age, as described previously (Hannan & Hunstad, 2016; 
Hung, Dodson, & Hultgren, 2009). Experiments were 
conducted similarly in Gli1-tdTomato+ mice, with the 
addition of three doses of tamoxifen (0.1  mg/kg IP in 
corn oil/3% ethanol; Sigma) ending 10 days before UTI 
initiation.
2.3 | TGFβ1 receptor inhibition experiments
For TGFβ1 receptor inhibition experiments, mice were 
treated as described above, and treated with the ALK5-
specific inhibitor GW788388 (Gellibert et al., 2006) (Selleck 
Chemicals), 3 mg/kg IP with 6% DMSO in PBS, daily for 
7  days beginning 1  day prior to UTI initiation. Mice were 
sacrificed 7 dpi as described below.
2.4 | Determination of bacterial loads
At the indicated time points, mice were terminally anesthe-
tized with inhaled isoflurane (Patterson Veterinary, Greeley, 
CO) and perfused with 4°C PBS via the left ventricle. 
Bladders and kidneys were aseptically removed and homog-
enized in 4°C PBS; tissue homogenates were serially diluted 
and plated on LB agar.
2.5 | Serum analysis
Blood was collected by submandibular puncture, or by car-
diac puncture for collections at the time of sacrifice, into 
BD Microtainer serum separator tubes and centrifuged at 
10,000g. Serum testosterone and estradiol measurements 
were performed by enzyme immunoassay at the Ligand 
Assay and Analysis Core, University of Virginia Center for 
Research in Reproduction.
2.6 | Quantitative RT-PCR
At various time points, mRNA was extracted from flash-fro-
zen kidneys with RNA Stat-60 (Amsbio), according to manu-
facturer's instructions. 1 µg mRNA was converted to cDNA 
with the iScript cDNA Synthesis Kit (Bio-Rad) according to 
the manufacturer's instructions. Roughly 20 ng of cDNA was 
run in triplicate with SsoAdvanced Universal SYBR Green 
Supermix (Bio-Rad) containing 350  nM primers. Thermal 
cycling was performed using an Applied Biosystems Fast 
7500 RT-PCR system with the following protocol: 95°C, 
3 min; 40 × (95°C, 10 s; 60°C, 30 s). Primers used in this 
study are provided in Table S1.
2.7 | Tissue preparation and histology
Mice were euthanized as described above, and excised kid-
neys were fixed in 4% paraformaldehyde in PBS at 4°C for 
1 hr, then incubated overnight in 30% sucrose in PBS at 4°C 
before embedding into OCT (Fisher Scientific). Embedded 
tissues were cryosectioned into 5- to 8-µm sections and 
mounted on Superfrost Plus slides (Fisher Scientific). 
Gomori trichrome staining was performed with the Gomori 
Trichrome Stain Kit (Richard-Allan Scientific) according to 
the manufacturer's instructions.
For immunohistochemistry, sections were washed with 
Tris-buffered saline (TBS; 50  mM Tris, 150  mM NaCl, 
pH 7.6), incubated with 3% H2O2 in methanol, washed 
with TBS, and blocked with 10% fetal bovine serum 
(FBS; Gibco, Dublin, Ireland) in TBS. Sections were then 
stained for collagen I (1:250, SouthernBiotech #1310-
01, RRID:AB_2753206), washed with TBS, and probed 
with 1:250 biotinylated anti-goat IgG (Invitrogen #31730, 
RRID:AB_228368), then washed with TBS and probed 
again with 1:250 streptavidin-HRP (ThermoFisher Scientific 
#N504). After washing, sections were developed with DAB 
(Vector Laboratories #SK-4100), according to the manufac-
turer's instructions. Sections were washed again, and dyed 
with Gill No. 2 Hematoxylin (Sigma) before dehydration and 
mounting. For analysis, 10 random images of each section 
were taken at 10× magnification, and quantified using the 
IHC profiler plugin for ImageJ (National Institutes of Health; 
Bethesda, MD (Varghese, Bukhari, Malhotra, & De, 2014)). 
Representative IHC images are presented in Figure S6.
For immunofluorescence microscopy, sections were 
washed with PBS, blocked with 10% FBS in PBS, and stained 
with primary antibodies against CD140b (APB5)-APC 
(1:200, eBioscience #14-1402, RRID:AB_467493), αSMA 
(1A4/asm-1)-PerCP (1:150, Novus Biologicals #NBP2-
34522PCP), aquaporin 2 (E2)-AlexaFluor 647 (1:200, Santa 
Cruz Biotechnology #sc-515770, RRID:AB_2810957), 
aquaporin 1 (B-11)-AlexaFluor 647 (1:200, Santa Cruz 
Biotechnology #sc-25287, RRID:AB_626694), Tamm-
Horsfall protein (774056) (THP, uromodulin; 1:200, 
ThermoFisher #MA5-24374, RRID:AB_2606307), cal-
bindin D28k (D-4)-AlexaFluor 647 (1:200, Santa Cruz 
Biotechnology #sc-365360, RRID:AB_10841576), 
or TGFβ1 (3C11)-AlexaFluor 594 (1:200, Santa Cruz 
Biotechnology #sc-130348, RRID:AB_1567351). Sections 
were washed with PBS and probed when necessary with a 
goat anti-rabbit AlexaFluor 488-conjugated secondary an-
tibody (1:300, Jackson ImmunoResearch #111-095-144, 
RRID:AB_2337978). Sections were then stained with 
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1:5,000 4′,6-diamidino-2-phenylindole (DAPI) and mounted 
with ProLong Gold (both from Life Technologies). Images 
were captured digitally using a Zeiss LSM 880 Airyscan con-
focal microscope.
2.8 | Flow cytometry
Kidneys were harvested as described above and manually 
homogenized into 4°C RPMI (Gibco), then treated with 
RBC lysis buffer (155 mM NH4Cl, 10 mM KHCO3) at room 
temperature to ensure lysis of any RBCs remaining after per-
fusion. After washing, cells were resuspended in 4°C PBS 
and stained with Live/Dead Fixable Yellow (ThermoFisher 
Scientific). After staining and washing, cells were resus-
pended in 4°C FACS buffer (10% FBS, 1% w/v sodium 
azide in PBS) and treated with Fc Block (BD Biosciences) 
on ice, then stained with labeled antibodies against the fol-
lowing extracellular antigens: E-cadherin (CD324)-PE-Cy7 
(1:200, Biolegend #147309, RRID:AB_2564187), nestin 
(Rat-401)-FITC (1:20, Santa Cruz Biotechnology #sc-33677, 
RRID:AB_627995), CD140b (APB5)-APC (1:20, Biolegend 
#136008, RRID:AB_2268091), and CD45 (30-F11)-BV510 
(1:200, BD Biosciences #563891, RRID:AB_2734134). 
Cells were washed again, fixed in 4% paraformaldehyde in 
PBS, and permeabilized on ice with Perm/Wash buffer (10% 
FBS, 1% w/v sodium azide, 1.3 mM saponin in PBS, pH 7.4–
7.6). The cells were then stained with the following labeled 
intracellular antibodies: Gli1 (C-1)-PE (1:25, Santa Cruz 
Biotechnology #sc-515751), αSMA (1A4/asm-1)-PerCP 
(1:10, Novus Biologicals #NBP2-34522PCP), and TGFβ1 
(9016)-AlexaFluor 700 (1:50, R&D Systems #IC240N, 
RRID:AB_884506). After staining, cells were washed, re-
suspended in FACS buffer, and subjected to flow cytometry 
on an LSR II Fortessa instrument (BD Biosciences); results 
were analyzed using FlowJo software (Tree Star Inc.). A rep-
resentation of the gating scheme used for analysis is provided 
in Figure S7.
2.9 | Immunoblotting
Kidneys were harvested as described above, flash frozen in 
liquid nitrogen, and stored at −80°C until use. They were ho-
mogenized in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 
1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, pH 
7.4) containing PhosSTOP phosphatase inhibitor and cOm-
plete Mini protease inhibitor (both from Roche). Lysates 
were cleared by centrifugation (2 × 5 min at max speed), and 
total protein concentration was determined by bicinchoninic 
acid assay (Invitrogen). 80  µg protein per lane was loaded 
into SDS-PAGE gels and transferred to PVDF membranes. 
Membranes were blocked with 5% milk (Carnation) in PBS 
with 0.05% Tween-20 (PBST) and probed with primary anti-
bodies for Smad2/3 (C-8) (1:500, Santa Cruz Biotechnology 
#sc-133098, RRID::AB_2193048) and CoxIV (1:20,000, 
Cell Signaling Technologies #4844, RRID:AB_2085427) 
overnight at 4°C. Membranes were then washed with 
PBST and probed with respective horseradish peroxidase-
conjugated secondary antibodies (GE Healthcare #NA931, 
RRID:AB_772210 and #NA934, RRID:AB_772206) at 
1:2000 in blocking buffer for 1  hr at room temperature. 
Membranes were washed again with PBST and developed 
with Clarity Western ECL Kit (Bio-Rad). Western blots were 
quantified using the Analyze Gels plugin on ImageJ.
2.10 | Statistical analysis
Organ bacterial loads and IHC quantification were compared 
using the nonparametric Mann–Whitney U test. All other 
comparisons were made using an unpaired t test. p values 
<.05 were considered significant.
3 |  RESULTS
3.1 | Androgens augment TGFβ1 
production in the kidney
To investigate the effect of androgens on renal fibrosis follow-
ing pyelonephritis, female C57BL/6 mice were treated weekly 
with 150  mg/kg of testosterone cypionate (TC) or vehicle 
beginning 2  weeks before UPEC inoculation. Mice treated 
with TC had significantly higher levels of serum testosterone 
compared to vehicle-treated mice, accompanied by mild but 
detectable increases in serum estradiol levels, presumably 
via aromatization (Figure S1). Consistent with our prior data 
showing more severe UTI outcomes in androgenized hosts, 
TC-treated mice harbored significantly higher bladder and 
kidney bacterial loads at later time points (14 and 28 dpi), 
with a higher proportion of TC-treated mice exhibiting high-
titer pyelonephritis (>104 CFU; Figure S2). Elevation of cir-
culating androgens increased both expression and production 
of TGFβ1 globally in the kidney. Transcript levels of Tgfb1 in 
the whole kidney were slightly higher at the time of infection 
and were significantly higher in TC-treated mice 1-day post-
infection (Figure  1a). Flow cytometry analysis determined 
that at baseline (prior to initiation of UTI), increased TGFβ1 
protein expression in TC-treated mice was observed only in 
non-hematopoietic (CD45−) cell populations comprising the 
renal parenchyma. Among these CD45− subsets, TGFβ1 
production by renal epithelial cells (E-cadherin+, CD45−) 
peaked early (1 dpi) in response to UPEC infection in both 
vehicle- and TC-treated mice. TGFβ1 protein production by 
epithelial cells in the kidneys of TC-treated mice was also 
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increased compared to those of vehicle-treated mice 1 and 
7 dpi (Figure 1b). Immunofluorescence microscopy revealed 
TGFβ1 production throughout the nephron but primarily in 
the thick ascending loop and distal tubule in both vehicle and 
TC-treated mice, both before and 1 day post infection, with 
no significant TGFβ1 production in the medulla (Figure 2, 
Figure S3). Meanwhile, TGFβ1 production by non-epithelial 
cell subsets (CD45−, E-cadherin−; comprising endothelial 
cells, vascular smooth muscle cells, podocytes, mesangial 
cells, fibroblasts, and activated myofibroblasts) was consist-
ently higher in TC-treated mice than in vehicle-treated mice 
across all time points (0–28  dpi), steadily increasing over 
time only in TC-treated mice (Figure 1c).
3.2 | Increased early TGFβ1 perturbs 
levels of downstream fibrotic signaling factors
In other global kidney injury models (e.g., unilateral ure-
teral obstruction [UUO]), increased TGFβ1 production in 
the kidney alters the ratio of transcription factors Smad2 
and Smad3, favoring activation of fibrosis programs (Kim 
et al., 2005). In addition, testosterone treatment of cultured 
ovarian epithelial cells was shown to suppress Smad3 pro-
duction (Kollara, Shathasivam, Park, Ringuette, & Brown, 
2020). At the time points noted above after UPEC infection 
of C57BL/6 mice, we performed quantitative immunoblots 
on whole kidney homogenates for total Smad2 and Smad3 
(Figure 3a). Kidneys of TC-treated mice exhibited a higher 
Smad2:Smad3 ratio than vehicle-treated mice, beginning be-
fore the onset of UTI and continuing throughout the course 
of infection (Figure 3b). Of note, we could not reliably detect 
phospho-Smad2 and phospho-Smad3 in these homogenates 
despite multiple approaches (see Discussion). By qPCR anal-
ysis of whole-kidney RNA, Smad2 expression in TC-treated 
mice was statistically equivalent to that in vehicle-treated 
mice across the course of infection (Figure 3c), while Smad3 
expression was significantly suppressed in TC-treated mice 
at 7 dpi, recovering by 28 dpi (Figure 3d). These data indicate 
that androgen exposure facilitates Smad3 suppression in the 
infected kidney, thereby promoting fibrosis after infectious 
injury.
3.3 | Androgen exposure augments TGFβ1-
driven myofibroblast activation
TGFβ1 signaling in other renal injury models recruits 
Gli1+ MSC-like progenitor cells from the perivascular space 
and promotes the conversion of these cells and Gli1− kid-
ney-resident MSC-like cells into activated myofibroblasts 
capable of depositing extracellular matrix components, in-
cluding collagens (Asada et al., 2011; Kramann, Schneider, 
et al., 2015; Wan et al., 2012; Wu et al., 2013). We used flow 
cytometry to interrogate the effect of androgen exposure on 
the populations of kidney-resident MSC-like cells (CD45−, 
E-cadherin−, PDGFRβ+, Gli1−; consisting of fibroblasts, 
mesangial cells, and pericytes (Boor, Ostendorf, & Floege, 
2014; Klinkhammer, Floege, & Boor, 2018; Wu et al., 
2013)) and activated myofibroblasts (CD45−, E-cadherin−, 
PDGFRβ+, Gli1+, αSMA+, and Nestin+ (Humphreys, 2018; 
Kramann, Schneider, et al., 2015)) in the kidney before and 
throughout UPEC pyelonephritis. Prior to the onset of UTI, 
the kidneys of TC-treated mice harbored slightly more MSC-
like cells (Figure 4a) and significantly more activated myofi-
broblasts (Figure 4b) than in vehicle-treated mice. Moreover, 
F I G U R E  1  TGFβ1 levels are upregulated in the kidneys of TC-treated mice. Female C57BL/6 mice were injected weekly with 150 mg/kg 
testosterone cypionate (TC) or vehicle starting at 5 weeks of age before transurethral inoculation of 107 CFU of UPEC 2 weeks later. (a) Relative 
mRNA transcript levels of Tgfb1 (normalized to Gapdh) in vehicle-treated (open bars) or TC-treated (gray bars) mice at various time points before 
and after UPEC inoculation; n = 4–8 mice per group, mean transcript level in vehicle-treated mice set to 1 arbitrary unit at each time point. Relative 
mean fluorescence intensity (MFI) of TGFβ1 in (b) epithelial and (c) non-epithelial cells, shown as a proportion of the MFI of live, CD45− cells, 
was determined by flow cytometry of whole kidney in vehicle-treated (open triangles) or TC-treated (filled triangles) mice; n = 4–12 mice per 
group. *p < .05, **p < .01, ***p < .001
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the relative amount of TGFβ1 produced at baseline in both 
the MSC-like cells (Figure 4c) and activated myofibroblasts 
(Figure 4d) was significantly higher in TC-treated mice. This 
augmented recruitment of MSC-like cells and activation of 
myofibroblasts, in conjunction with their increased TGFβ1 
expression, suggests that androgen exposure “primes” these 
cell populations within the kidney for fibrotic signaling, even 
before renal injury occurs.
Over a time course following UPEC inoculation, MSC-
like cells were significantly more populous in androgenized 
mice only at 7  dpi (Figure  5a). Meanwhile, the population 
of activated myofibroblasts was significantly elevated in 
TC-treated mice beginning 7 dpi (p = .0096 vs. TC-treated 
mice at 1 dpi), while in vehicle-treated mice, this population 
was elevated only much later (28  dpi; p  =  .0187 vs. vehi-
cle-treated mice at 14 dpi; Figure 5b). Of note, in uninfected 
mice treated with vehicle or TC and allowed to grow to ages 
equal to those 14 or 28 dpi (9- and 11-week old, respectively), 
populations of MSC-like cells resembled those in comparable 
UPEC-infected mice (Figure S4a). In contrast, the activated 
F I G U R E  2  TGFβ1 is produced in selected tubular segments in both vehicle and TC-treated mice. Immunofluorescence imaging of 8-µm 
sections of fixed, frozen kidneys shows that the TGFβ1 (red in all images) is primarily produced in the distal tubule (green, calbindin D28k) 
and thick ascending loop (green, Tamm-Horsfall protein [THP]), while TGFβ1 did not colocalize with the proximal tubule (green, aquaporin-1 
[AQP1]), or the collecting duct (green, aquaporin-2 [AQP2]) in vehicle- or TC-treated mice at the time of UPEC inoculation and 1 dpi. Scale bar 
represents 20 µm
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myofibroblast population was not significantly different be-
tween uninfected vehicle- and TC-treated mice (Figure S4b), 
indicating that the infectious injury was specifically required 
to induce myofibroblast activation.
Over time following UPEC infection, the amount of 
TGFβ1 produced by MSC-like cells and activated myo-
fibroblasts (on a per-cell basis) increased in both TC- and 
vehicle-treated mice (Figure  5c and d), similar to the time 
course of TGFβ1 transcription and production reported in 
other renal injury models (Kilari, Yang, Sharma, McCall, & 
Misra, 2018; Popova et al., 2010; Wu et al., 2013). In MSC-
like cells, TGFβ1 production was higher in TC-treated mice 
than in vehicle-treated mice only at 28 dpi (Figure 5c); this 
also occurred in uninfected TC-treated mice of similar age 
(Figure  S4c). TGFβ1 production in MSC-like cells rose 
in TC-treated mice over time (28 dpi vs. 14 dpi, p =  .026; 
Figure 5c). Similarly, per-cell TGFβ1 production by activated 
myofibroblasts in TC-treated mice was significantly higher 
than in vehicle-treated mice only at 14 dpi (Figure 5d), when 
the activated myofibroblast population was also compara-
tively greatest (Figure 5b). Immunofluorescence microscopy 
indicated that these activated myofibroblasts are the predom-
inant cellular sources of TGFβ1 within the kidney 14  dpi 
(Figure  S5). Although TC treatment of uninfected mice 
did significantly increase TGFβ1 production by activated 
myofibroblasts (Figure  S4d), this effect of androgenization 
was amplified in UPEC-infected mice (p = .026 vs. uninfected 
at 14 dpi; p = .039 at 28 dpi; Figure 5d). Taken together, these 
data indicate that the chief effect of androgen exposure is to 
enhance TGFβ1 production by multiple cell types within the 
kidney, leading to accelerated activation and proliferation of 
myofibroblasts upon subsequent UPEC-induced injury.
3.4 | Androgen-enhanced myofibroblast 
activation correlates with scar formation
Prior work indicates that local myofibroblast activation 
drives fibrotic scarring in non-infectious, global renal in-
jury models (Humphreys et al., 2010; Kramann, Schneider, 
et al., 2015; Picard, Baum, Vogetseder, Kaissling, & Le 
Hir, 2008; Sato & Yanagita, 2017). In comparison, our 
pyelonephritis model features regional injury and scar-
ring that is comparatively limited in scope; as a result, 
analysis of our whole-kidney homogenates did not reveal 
increased Col1A1 (collagen I) and Acta2 (α-smooth mus-
cle actin) transcription in TC-treated mice (Figure 6a and 
b). Quantified IHC staining indicated an increase in col-
lagen I deposition in the kidneys of TC-treated mice at 
14 dpi (Figure 6c), while collagen I staining had equalized 
F I G U R E  3  TC treatment alters the Smad2:Smad3 ratio throughout the course of infection. The ratio of Smad2 and Smad3 was determined 
by immunoblot (as exemplified with five individual vehicle- and TC-treated mice 14 dpi) in panel (a) and quantified in (b), at the time of UPEC 
inoculation and at 1, 7, 14 and 28 dpi in whole-kidney homogenates from vehicle-treated mice (open triangles) or TC-treated mice (filled triangles); 
n = 7–10 mice per group. The relative mRNA expression of (c) Smad2 and (d) Smad3 in whole kidney (normalized to Gapdh) was determined 
at the above time points in both vehicle-treated (open bars) and TC-treated (gray bars) mice; n = 4–8 mice per group. *p < .05, **p < .01, 
***p < .001
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between groups by 28 dpi. Furthermore, TC-treated mice 
developed regions of focal scarring visible (by Gomori 
trichrome staining) in the renal cortex by 14 dpi and per-
sisting through 28 dpi; such regions were not identified in 
vehicle-treated mice (Figure 6d). We performed analogous 
infections in TC-treated Gli1-tdTomato+ mice, and the re-
sulting scars contained streaks of activated myofibroblasts, 
which stained positively for αSMA, Gli1 (via the Tomato 
fluorophore), and PDGFRβ, and were surrounded by areas 
of dense collagen deposition (Figure 7). Activated myofi-
broblasts are normally present (in the absence of injury) 
in the renal medulla and near the vasculature (Kramann, 
Schneider, et al., 2015); in our infection model, these cells 
were visible in the medulla in both TC- and vehicle-treated 
mice (Figure 8a and c). However, they were found in corti-
cal locations only in TC-treated mice (Figure  8b and d), 
consistent with the localization of renal scars in these mice.
To further test whether androgen-enhanced TGFβ1 was 
driving myofibroblast activation and scarring following 
UPEC pyelonephritis, we administered a specific TGFβ1 
receptor antagonist (GW788388; (Gellibert et al., 2006; 
Lagares et al., 2010; McMillin et al., 2019; Petersen et al., 
2008)) to TC-treated mice for 7  days, beginning the day 
prior to UPEC inoculation. As seen in our initial experi-
ments (Figure 1), androgen treatment (vs. vehicle) increased 
TGFβ1 production by CD45− cell populations 7  dpi; as 
expected, this increase was unaltered by GW788388 treat-
ment (Figure 9a and b). Similarly, MSC-like cell numbers 
were increased by androgen treatment (vs. vehicle) and 
not further changed by GW788388 treatment (Figure 9c). 
However, GW788388 treatment did significantly diminish 
the activated myofibroblast population in androgenized 
kidneys (Figure  9d), consistent with a model in which 
TGFβ1 mediates androgen-enhanced renal scarring follow-
ing UPEC infection.
4 |  DISCUSSION
In this work, we demonstrate that renal fibrosis after ex-
perimental UPEC pyelonephritis is driven by TGFβ1 and 
enhanced by androgens. Specifically, androgen exposure 
augments the production of fibrotic signaling factors (includ-
ing TGFβ1) globally in the kidney, and alters the relative ex-
pression of the downstream transcription factors Smad2 and 
Smad3. In other models of renal fibrosis following non-infec-
tious insult, MSC-like cell populations residing in the kidney 
and recruited from circulating precursors become activated 
myofibroblasts after local exposure to TGFβ1, subsequently 
depositing extracellular matrix components around the in-
jured area that ultimately form a scar (Humphreys, 2018; 
Meng, Nikolic-Paterson, & Lan, 2016). Here, we show that 
an analogous process underlies scarring after UPEC pyelone-
phritis, and we delineate the cellular and molecular mecha-
nisms that are accelerated in the presence of androgens.
We previously showed that androgen exposure was linked 
to high-titer pyelonephritis and significant renal scarring in 
C3H/HeN mice (Olson et al., 2016), which feature vesico-
ureteral reflux as a risk factor for upper-tract UTI. In the pres-
ent work, we utilized non-refluxing C57BL/6 mice, which 
develop pyelonephritis of more modest severity after UPEC 
inoculation of the bladder. As we reported in the C3H back-
ground (Olson et al., 2016, 2018), androgen exposure was 
here found also to increase the rate of high-titer pyelone-
phritis in C57BL/6 mice. Compared with the extensive scars 
formed in UPEC-infected C3H mice (Olson et al., 2017), the 
BL/6 background enabled us to model of more limited renal 
scar formation, without overwhelming inflammation, and of-
fers many more readily available genetic tools to enable fu-
ture investigation.
F I G U R E  4  Increased TGFβ1 signaling primes TC-treated mice 
for fibrosis by increasing myofibroblast activation. The populations 
of (a) MSC-like cells and (b) activated myofibroblasts as a percentage 
of the total live, CD45− population at the time of infection were 
determined by flow cytometry in vehicle-treated (open triangles) or 
TC-treated mice (filled triangles). The MFI of TGFβ1 produced by 
(c) MSC-like cells and (d) activated myofibroblasts as a proportion of 
the MFI of live, CD45− cells of vehicle- or TC-treated mice was also 
determined by flow cytometry of whole kidney at the time of infection. 
n = 5 mice per group; ***p < .001
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Our qPCR and flow cytometric analyses showed that global 
TGFβ1 levels in the kidney were increased in androgenized 
mice even in the absence of injury. Androgenized mice exhib-
ited corresponding increases in the population of MSC-like 
F I G U R E  5  Androgen exposure 
influences fibroblast and myofibroblast 
activation and TGFβ1 production 
throughout the course of infection. The 
population of (a) MSC-like cells and (b) 
activated myofibroblasts as a percentage of 
live, CD45− cells was determined by flow 
cytometry of whole kidney in vehicle-
treated (open triangles) or TC-treated (filled 
triangles) mice at 1, 7, 14, and 28 dpi. 
The relative MFI of TGFβ1 production 
compared to live, CD45− cells in (c) MSC-
like cells and (d) activated myofibroblasts at 
the same time points was also determined by 
flow cytometry in vehicle- and TC-treated 
mice. n = 4–12 mice per group; *p < .05, 
**p < .01
F I G U R E  6  Increased myofibroblast 
activation in TC-treated mice is associated 
with early and persistent inflammation and 
scarring in the renal cortex. Relative mRNA 
expression of (a) Collagen I (Col1A1) and 
(b) αSMA (Acta2) compared to GAPDH in 
vehicle-treated (open bars) and TC-treated 
(gray bars) at the time of UPEC inoculation 
and 1, 7, 14, and 28 dpi. n = 6–8 mice 
per group. (c) Collagen I deposition was 
quantified after immunohistochemical 
staining of 8-µm sections of fixed, frozen 
kidneys of vehicle- and TC-treated mice at 
14 and 28 dpi. n = 102–136 random images 
from 12 to 15 sections from five mice per 
group. (d) 8-µm sections of fixed, frozen 
kidneys of vehicle- or TC-treated mice 
14 and 28 dpi were stained with Gomori 
trichrome, highlighting collagen in blue.  
**p < .01; scale bar represents 50 µm
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cells and activated myofibroblasts residing in the kidney be-
fore infectious insult. These data indicate that androgen ex-
posure itself promotes an environment that is primed for an 
enhanced fibrotic response should an injury occur. Indeed, 
male sex is reported as a risk factor for poor renal outcome 
(Eriksen & Ingebretsen, 2006; Evans et al., 2005; Iseki, 
Iseki, Ikemiya, & Fukiyama, 1996). Epidemiologic data 
from the United States, Europe and Japan show that kidney 
disease progresses faster in men than in women, resulting 
in men having a 60% greater incidence of end-stage kidney 
disease (Centers for Disease Control & Prevention, 2019; 
Gretz, Zeier, Geberth, Strauch, & Ritz, 1989; Neugarten & 
Golestaneh, 2013).
Once UPEC infection began, the TGFβ1 signaling cas-
cade was persistently more active in the androgenized host. 
Tgfb1 transcription was increased in TC-treated mice early 
in infection, with elevated TGFβ1 production observed in 
TC-treated mice was most evident in epithelial cells, pre-
dominantly in the distal nephron, earlier in infection (up to 
7 dpi) and then in non-epithelial (CD45−, E-cadherin−) cell 
types later in infection (7–28  dpi). This sequence is logi-
cal, as renal epithelial surfaces are likely contacted earliest 
by UPEC during ascending infection (Li et al., 2017; Olson 
et al., 2018). Thus, epithelial TGFβ1 signaling is likely the 
initiator of the fibrotic response to infection; in other models, 
TGFβ1 signaling from epithelial cells alone is sufficient to 
drive a fibrotic response to injury (Gentle et al., 2013; Olson 
et al., 2018).
The Smad2:Smad3 ratio was also consistently higher in 
the kidneys of TC-treated mice than in vehicle-treated mice 
throughout the course of infection, apparently driven primar-
ily by suppression of Smad3. Although phosphorylation of 
Smad2 and Smad3 is required for these transcription factors 
to translocate to the nucleus and promote transcription of 
ECM components (Meng et al., 2016), we were unable to 
successfully quantify phospho-Smad2/3 in the whole kidney 
despite several approaches. In contrast to other experimen-
tal renal injuries that are global (e.g., UUO), experimental 
pyelonephritis is a localized process, affecting only a lim-
ited portion of the kidney (Olson et al., 2016, 2017, 2018); 
as outlined above, this is particularly true in the BL/6 host 
and thereby limits our ability to discern changes in such ana-
lytes through analysis of whole-kidney homogenates. Further 
work will need to be done to demonstrate phospho-Smad2/3 
F I G U R E  7  Activated myofibroblasts are localized to regions of scarring in TC-treated mice. Immunofluorescence staining of 8-µm sections 
of fixed, frozen kidneys from TC-treated Gli1-tdTomato mice 28 dpi show that activated myofibroblasts stain positively for αSMA+ (violet), Gli1+ 
(red), and PDGFRβ+ (green). Gomori trichrome staining of the adjacent section demonstrates that the activated myofibroblasts reside in areas of 
high collagen deposition and inflammation. Scale bar represents 50 µm
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alterations at the cellular level in scarred areas, rather than 
globally throughout the kidney. However, an altered total 
Smad2:Smad3 ratio was also shown in vitro to be a hallmark 
of fibrotic signaling (Kim et al., 2005), lending support to our 
conclusion that these transcription factors are key mediators 
of the post-pyelonephritic scarring program.
F I G U R E  8  Activated myofibroblasts 
are localized to the renal cortex only in 
TC-treated mice. Immunofluorescence 
imaging of 8-µm sections of fixed, frozen 
kidneys from vehicle- or TC-treated Gli1-
tdTomato mice 28 dpi shows that activated 
myofibroblasts (αSMA+ (violet), Gli1+ 
(red), and PDGFRβ+ (green)) and MSC-
like cells (PDGFRβ+ alone) are identified 
in the medulla in mice receiving either 
TC (a) or vehicle (c), whereas activated 
myofibroblasts are observed in the renal 
cortex only in TC-treated mice (b), and 




F I G U R E  9  TGFβR1 inhibition 
limits androgen-enhanced myofibroblast 
activation. TGFβ1 production (MFI 
compared to live, CD45− cells) was 
measured 7 dpi in mice receiving vehicle/
vehicle (open triangles), TC/vehicle 
(filled triangles), or TC/GW788388 
(filled diamonds) in (a) epithelial and 
non-epithelial cells or (b) MSC-like cells 
and activated myofibroblasts. The relative 
population of (c) MSC-like cells and (d) 
activated myofibroblasts as a percentage 
of live, CD45− cells was also determined 
in these groups. n = 5–10 mice per group; 
*p < .05, **p < .01, ***p < .001
12 of 14 |   HREHA Et Al.
Ultimately, TGFβ1 signaling in the infected kidney pro-
motes the recruitment of precursors and the activation of my-
ofibroblasts following the initiation of UTI. These αSMA+, 
Gli1+, PDGFRβ  +  cells are visible in the post-pyelone-
phritic scar as it forms and matures, and they become the 
predominant producers of TGFβ1 during resolving infection. 
Activated myofibroblasts were observed in the medulla inde-
pendent of androgen exposure, while myofibroblasts within 
collagen-rich cortical scars were observed only in the an-
drogenized host. Global collagen I deposition (by IHC) was 
enhanced in TC-treated mice at 14 dpi, but matched in vehi-
cle-treated mice by 28 dpi, indicating that the acceleration of 
myofibroblast activation in the androgenized host mediated 
a pro-scarring response earlier in the course of infection. 
Moreover, administration of a TGFβ receptor antagonist did 
not alter global TGFβ1 production in the kidney early in in-
fection, but did result in reduction of the activated myofibro-
blast population in the injured, androgenized (and therefore 
scar-susceptible) host. Along these lines, a detailed under-
standing of the molecular and cellular basis of post-infectious 
scar formation, as well as hormonal and other influences on 
this injury response, may illuminate specific interventions to 
mitigate scarring after infection, promote functional paren-
chymal healing, and reduce long-term complications.
ACKNOWLEDGMENTS
This work was supported by NIH grants P50-DK064540 and 
R01-DK111541 (to D.A.H.). T.N.H. was supported by NIH 
grant T32-DK007126. The LSM880 Airyscan confocal mi-
croscope was purchased with support from the NIH Office 
of Research Infrastructure Programs (ORIP) under grant 
S10-OD021629. We thank B. Humphreys for Gli1-tdTomato 
mice and consultation, K. Hruska for advice and C. Albracht 
for technical assistance.
CONFLICT OF INTEREST
D.A.H. serves on the Board of Directors for BioVersys AG, 
Basel, Switzerland. All other authors have no potential con-
flicts to declare.
ORCID
David A. Hunstad   https://orcid.org/0000-0002-9848-0975 
REFERENCES
Agapova, O. A., Fang, Y., Sugatani, T., Seifert, M. E., & Hruska, K. A. 
(2016). Ligand trap for the activin type IIA receptor protects against 
vascular disease and renal fibrosis in mice with chronic kidney dis-
ease. Kidney International, 89, 1231–1243.
Asada, N., Takase, M., Nakamura, J., Oguchi, A., Asada, M., Suzuki, 
N., … Yanagita, M. (2011). Dysfunction of fibroblasts of extrarenal 
origin underlies renal fibrosis and renal anemia in mice. Journal of 
Clinical Investigation, 121, 3981–3990.
Bauman, K. A., Wettlaufer, S. H., Okunishi, K., Vannella, K. M., 
Stoolman, J. S., Huang, S. K., … Peters-Golden, M. (2010). The 
antifibrotic effects of plasminogen activation occur via prostaglandin 
E2 synthesis in humans and mice. Journal of Clinical Investigation, 
120, 1950–1960.
Boor, P., Ostendorf, T., & Floege, J. (2014). PDGF and the progression 
of renal disease. Nephrology, Dialysis, Transplantation, 29(Suppl 
1), i45–i54.
Calderon-Margalit, R., Golan, E., Twig, G., Leiba, A., Tzur, D., Afek, 
A., … Vivante, A. (2018). History of childhood kidney disease 
and risk of adult end-stage renal disease. New England Journal of 
Medicine, 378, 428–438.
Centers for Disease Control and Prevention. (2019). Chronic kidney dis-
ease surveillance system—United States. [Online]. http://www.cdc.
gov/CKD [11 Jul. 2019].
Chen, G., Lin, S.-C., Chen, J., He, L., Dong, F., Xu, J., … Wang, Y. 
(2011). CXCL16 recruits bone marrow-derived fibroblast precursors 
in renal fibrosis. Journal of the American Society of Nephrology, 22, 
1876–1886.
Chen, S. L., Hung, C. S., Pinkner, J. S., Walker, J. N., Cusumano, C. 
K., Li, Z., … Hultgren, S. J. (2009). Positive selection identifies an 
in vivo role for FimH during urinary tract infection in addition to 
mannose binding. Proceedings of the National Academy of Sciences 
of the United States of America, 106, 22439–22444.
Efstathiou, S. P., Pefanis, A. V., Tsioulos, D. I., Zacharos, I. D., 
Tsiakou, A. G., Mitromaras, A. G., … Mountokalakis, T. D. 
(2003). Acute pyelonephritis in adults: Prediction of mortal-
ity and failure of treatment. Archives of Internal Medicine, 163, 
1206–1212.
Eriksen, B. O., & Ingebretsen, O. C. (2006). The progression of chronic 
kidney disease: A 10-year population-based study of the effects of 
gender and age. Kidney International, 69, 375–382.
Evans, M., Fryzek, J. P., Elinder, C. G., Cohen, S. S., McLaughlin, J. 
K., Nyrén, O., & Fored, C. M. (2005). The natural history of chronic 
renal failure: Results from an unselected, population-based, incep-
tion cohort in Sweden. American Journal of Kidney Diseases, 46, 
863–870.
Foxman, B. (2002). Epidemiology of urinary tract infections: Incidence, 
morbidity, and economic costs. American Journal of Medicine, 
113(Suppl 1A), 5S–13S.
Foxman, B., Barlow, R., D’Arcy, H., Gillespie, B., & Sobel, J. D. (2000). 
Urinary tract infection: Self-reported incidence and associated costs. 
Annals of Epidemiology, 10, 509–515.
Foxman, B., Klemstine, K. L., & Brown, P. D. (2003). Acute pyelo-
nephritis in US hospitals in 1997: Hospitalization and in-hospital 
mortality. Annals of Epidemiology, 13, 144–150.
Gamal, D., Elkholi, E., & Nagy, H. M. (2016). The endocrine-metabolic 
disorders and adverse pregnancy outcomes in metabolically obese 
normal weight women with polycystic ovary syndrome. Journal of 
Women's Health and Gynecology, 2, 31.
Gellibert, F., de Gouville, A. C., Woolven, J., Mathews, N., Nguyen, 
V. L., Bertho-Ruault, C., … Huet, S. (2006). Discovery of 
4-{4-[3-(Pyridin-2-yl)-1 H -pyrazol-4-yl]pyridin-2-yl}- N -(tetrahy-
dro-2 H - pyran-4-yl)benzamide (GW788388): A potent, selective, 
and orally active transforming growth factor-β type I receptor inhib-
itor. Journal of Medicinal Chemistry, 49, 2210–2221.
Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A., & Boor, 
P. (2014). The extracellular matrix in the kidney: A source of novel 
non-invasive biomarkers of kidney fibrosis? Fibrogenes Tissue 
Repair, 7, 4.
Gentle, M. E., Shi, S., Daehn, I., Zhang, T., Qi, H., Yu, L., … Bottinger, 
E. P. (2013). Epithelial cell TGFβ signaling induces acute tubular 
   | 13 of 14HREHA Et Al.
injury and interstitial inflammation. Journal of the American Society 
of Nephrology, 24, 787–799.
Gretz, N., Zeier, M., Geberth, S., Strauch, M., & Ritz, E. (1989). Is 
gender a determinant for evolution of renal failure? A study in au-
tosomal dominant polycystic kidney disease. American Journal of 
Kidney Diseases, 14, 178–183.
Hannan, T. J., & Hunstad, D. A. (2016). A murine model for escherichia 
coli urinary tract infection. Methods in Molecular Biology, 1333, 
159–175.
Hill, C. S. (2009). Nucleocytoplasmic shuttling of Smad proteins. Cell 
Research, 19, 36–46.
Hummers-Pradier, E., Ohse, A. M., Koch, M., Heizmann, W. R., & 
Kochen, M. M. (2004). Urinary tract infection in men. International 
Journal of Clinical Pharmacology and Therapeutics, 42, 360–366.
Humphreys, B. D. (2018). Mechanisms of renal fibrosis. Annual Review 
of Physiology, 10, 309–326.
Humphreys, B. D., Lin, S. L., Kobayashi, A., Hudson, T. E., Nowlin, B. 
T., Bonventre, J. V., … Duffield, J. S. (2010). Fate tracing reveals 
the pericyte and not epithelial origin of myofibroblasts in kidney 
fibrosis. American Journal of Pathology, 176, 85–97.
Hung, C. S., Dodson, K. W., & Hultgren, S. J. (2009). A murine model 
of urinary tract infection. Nature Protocols, 4, 1230–1243.
Inman, G. J., Nicolás, F. J., & Hill, C. S. (2002). Nucleocytoplasmic 
shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor 
activity. Molecular Cell, 10, 283–294.
Iseki, K., Iseki, C., Ikemiya, Y., & Fukiyama, K. (1996). Risk of devel-
oping end-stage renal disease in a cohort of mass screening. Kidney 
International, 49, 800–805.
Iwano, M., Plieth, D., Danoff, T. M., Xue, C., Okada, H., & Neilson, E. 
G. (2002). Evidence that fibroblasts derive from epithelium during 
tissue fibrosis. Journal of Clinical Investigation, 110, 341–350.
Ki, M., Park, T., Choi, B., & Foxman, B. (2004). The epidemiology of 
acute pyelonephritis in South Korea, 1997–1999. American Journal 
of Epidemiology, 160, 985–993.
Kilari, S., Yang, B., Sharma, A., McCall, D. L., & Misra, S. (2018). 
Increased transforming growth factor beta (TGF-β) and pSMAD3 
signaling in a murine model for contrast induced kidney injury. 
Scientific Reports, 8, 6630.
Kim, S. G., Kim, H. A., Jong, H. S., Park, J. H., Kim, N. K., Hong, S. H., 
… Bang, Y. J. (2005). The endogenous ratio of Smad2 and Smad3 
influences the cytostatic function of Smad3. Molecular Biology of 
the Cell, 16, 4672–4683.
Klinkhammer, B. M., Floege, J., & Boor, P. (2018). PDGF in organ fi-
brosis. Molecular Aspects of Medicine, 62, 44–62.
Kollara, A., Shathasivam, P., Park, S., Ringuette, M. J., & Brown, T. J. 
(2020). Increased androgen receptor levels and signaling in ovarian 
cancer cells by VEPH1 associated with suppression of SMAD3 and 
AKT activation. Journal of Steroid Biochemistry and Molecular 
Biology, 196.
Kramann, R. (2016). Hedgehog Gli signalling in kidney fibrosis. 
Nephrology, Dialysis, Transplantation, 31, 1989–1995.
Kramann, R., Fleig, S. V., Schneider, R. K., Fabian, S. L., DiRocco, 
D. P., Maarouf, O., … Humphreys, B. D. (2015). Pharmacological 
GLI2 inhibition prevents myofibroblast cell-cycle progression and 
reduces kidney fibrosis. Journal of Clinical Investigation, 125, 
2935–2951.
Kramann, R., Schneider, R. K., DiRocco, D. P., Machado, F., Fleig, S., 
Bondzie, P. A., … Humphreys, B. D. (2015). Perivascular Gli1+ 
progenitors are key contributors to injury-induced organ fibrosis. 
Cell Stem Cell, 16, 51–66.
Lagares, D., García-Fernández, R. A., Jiménez, C. L., Magán-Marchal, 
N., Busnadiego, O., Lamas, S., & Rodríguez-Pascual, F. (2010). 
Endothelin 1 contributes to the effect of transforming growth factor 
β1 on wound repair and skin fibrosis. Arthritis and Rheumatism, 62, 
878–889.
Li, B., Haridas, B., Jackson, A. R., Cortado, H., Mayne, N., Kohnken, 
R., … Becknell, B. (2017). Inflammation drives renal scarring in ex-
perimental pyelonephritis. American Journal of Physiology-Renal 
Physiology, 312, F43–F53.
Lipsky, B. A. (1989). Urinary tract infections in men. Epidemiology, 
pathophysiology, diagnosis and treatment. Annals of Internal 
Medicine, 110, 138–150.
Loeffler, I., & Wolf, G. (2014). Transforming growth factor-β and the 
progression of renal disease. Nephrology, Dialysis, Transplantation, 
29(Suppl 1), i37–i45.
McMillin, M., Grant, S., Frampton, G., Petrescu, A. D., Williams, E., 
Jefferson, B., & DeMorrow, S. (2019). The TGFβ1 receptor antag-
onist GW788388 reduces JNK activation and protects against ac-
etaminophen hepatotoxicity in mice. Toxicological Sciences, 170, 
549–561.
Meng, X. M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016). TGF-β: 
The master regulator of fibrosis. Nature Reviews Nephrology, 12, 
325–338.
Neugarten, J., & Golestaneh, L. (2013). Gender and the prevalence and 
progression of renal disease. Advances in Chronic Kidney Disease, 
20, 390–395.
Ng, Y. Y., Huang, T. P., Yang, W. C., Chen, Z. P., Yang, A. H., Mu, W., 
… Lan, H. Y. (1998). Tubular epithelial-myofibroblast transdiffer-
entiation in progressive tubulointerstitial fibrosis in 5/6 nephrecto-
mized rats. Kidney International, 54, 864–876.
Nicolle, L. E., Friesen, D., Harding, G. K., & Roos, L. L. (1996). 
Hospitalization for acute pyelonephritis in Manitoba, Canada, 
during the period from 1989 to 1992; impact of diabetes, pregnancy, 
and aboriginal origin. Clinical Infectious Diseases, 22, 1051–1056.
Olson, P. D., Hruska, K. A., & Hunstad, D. A. (2016). Androgens en-
hance male urinary tract infection severity in a new model. Journal 
of the American Society of Nephrology, 27, 1625–1634.
Olson, P. D., McLellan, L. K., Hreha, T. N., Liu, A., Briden, K. E., 
Hruska, K. A., & Hunstad, D. A. (2018). Androgen exposure poten-
tiates formation of intratubular communities and renal abscesses by 
Escherichia coli. Kidney International, 94, 502–513.
Olson, P. D., McLellan, L. K., Liu, A., Briden, K. L., Tiemann, K. M., 
Daugherty, A. L., … Hunstad, D. A. (2017). Renal scar formation 
and kidney function following antibiotic-treated murine pyelone-
phritis. Disease Models & Mechanisms, 10, 1371–1379.
Petersen, M., Thorikay, M., Deckers, M., van Dinther, M., Grygielko, 
E. T., Gellibert, F., … Laping, N. J. (2008). Oral administration of 
GW788388, an inhibitor of TGF-β type I and II receptor kinases, 
decreases renal fibrosis. Kidney International, 73, 705–715.
Picard, N., Baum, O., Vogetseder, A., Kaissling, B., & Le Hir, M. 
(2008). Origin of renal myofibroblasts in the model of unilateral 
ureter obstruction in the rat. Histochemistry and Cell Biology, 130, 
141–155.
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011). Role of endotheli-
al-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic 
disorders. American Journal of Pathology, 179, 1074–1080.
Popova, A. P., Bozyk, P. D., Goldsmith, A. M., Linn, M. J., Lei, J., 
Bentley, J. K., & Hershenson, M. B. (2010). Autocrine production of 
TGF-β1 promotes myofibroblastic differentiation of neonatal lung 
14 of 14 |   HREHA Et Al.
mesenchymal stem cells. American Journal of Physiology-Lung 
Cellular and Molecular Physiology, 298, L735–L743.
Reich, B., Schmidbauer, K., Rodriguez Gomez, M., Johannes Hermann, 
F., Göbel, N., Brühl, H., … Mack, M. (2013). Fibrocytes develop 
outside the kidney but contribute to renal fibrosis in a mouse model. 
Kidney International, 84, 78–89.
Ricardo, A. C., Yang, W., Sha, D., Appel, L. J., Chen, J., Krousel-Wood, 
M., … Lash, J. P. (2019). Sex-related disparities in CKD progres-
sion. Journal of the American Society of Nephrology, 30, 137–146.
Ruben, F. L., Dearwater, S. R., Norden, C. W., Kuller, L. H., Gartner, K., 
Shalley, A., … Bochicchio G.. (1995). Clinical infections in the non-
institutionalized geriatric age group: Methods utilized and incidence 
of infections: The Pittsburgh good health study. American Journal 
of Epidemiology, 141, 145–157.
Sato, Y., & Yanagita, M. (2017). Resident fibroblasts in the kidney: 
A major driver of fibrosis and inflammation. Inflammation and 
Regeneration, 37, 17.
Schnaper, H. W., Hayashida, T., Hubchak, S. C., & Poncelet, A. C. 
(2003). TGF-β signal transduction and mesangial cell fibrogen-
esis. American Journal of Physiology. Renal Physiology, 284, 
F243–F252.
Shaikh, N., Mattoo, T. K., Keren, R., Ivanova, A., Cui, G., Moxey-
Mims, M., … Hoberman, A. (2016). Early antibiotic treatment for 
pediatric febrile urinary tract infection and renal scarring. JAMA 
Pediatrics, 170, 848.
Shaikh, N., Morone, N. E., Bost, J. E., & Farrell, M. H. (2008). 
Prevalence of urinary tract infection in childhood: A meta-analysis. 
The Pediatric Infectious Disease Journal, 27, 302–308.
Varghese, F., Bukhari, A. B., Malhotra, R., & De, A. (2014). IHC 
Profiler: An open source plugin for the quantitative evaluation and 
automated scoring of immunohistochemistry images of human tis-
sue samples. PLoS ONE, 9, e96801.
Wan, M., Li, C., Zhen, G., Jiao, K., He, W., Jia, X., … Cao, X. (2012). 
Injury-activated transforming growth factor β controls mobilization 
of mesenchymal stem cells for tissue remodeling. Stem Cells, 30, 
2498–2511.
Wang, X. M., Zhang, Y., Kim, H. P., Zhou, Z., Feghali-Bostwick, C. 
A., Liu, F., … Choi, A. M. K. (2006). Caveolin-1: A critical reg-
ulator of lung fibrosis in idiopathic pulmonary fibrosis. Journal of 
Experimental Medicine, 203, 2895–2906.
Wang, Y. C., Su, H. Y., Liu, J. Y., Chang, F. W., & Chen, C. H. (2005). 
Maternal and female fetal virilization caused by pregnancy luteo-
mas. Fertility and Sterility, 84(509), e15–509.e17.
Wettergren, B., Jodal, U., & Jonasson, G. (1985). Epidemiology of bac-
teriuria during the first year of life. Acta Pædiatr Scandinavica, 74, 
925–933.
Wu, C. F., Chiang, W. C., Lai, C. F., Chang, F. C., Chen, Y. T., Chou, 
Y. H., … Lin, S. L. (2013). Transforming growth factor β-1 stimu-
lates profibrotic epithelial signaling to activate pericyte-myofibro-
blast transition in obstructive kidney fibrosis. American Journal of 
Pathology, 182, 118–131.
Xavier, S., Vasko, R., Matsumoto, K., Zullo, J. A., Chen, R., Maizel, J., 
… Goligorsky, M. S. (2015). Curtailing endothelial TGF-β signal-
ing is sufficient to reduce endothelial-mesenchymal transition and 
fibrosis in CKD. Journal of the American Society of Nephrology, 
26, 817–829.
Yamashita, S., Maeshima, A., Kojima, I., & Nojima, Y. (2004). Activin 
A is a potent activator of renal interstitial fibroblasts. Journal of the 
American Society of Nephrology, 15, 91–101.
Zeisberg, M., Hanai, J., Sugimoto, H., Mammoto, T., Charytan, D., 
Strutz, F., & Kalluri, R. (2003). BMP-7 counteracts TGF-β1–in-
duced epithelial-to-mesenchymal transition and reverses chronic 
renal injury. Nature Medicine, 9, 964–968.
Zhang, J., Tian, X. J., & Xing, J. (2016). Signal transduction pathways 
of EMT induced by TGF-β, SHH, and WNT and their crosstalks. 
Journal of Clinical Medicine, 5, E41.
SUPPORTING INFORMATION
Additional supporting information may be found online in 
the Supporting Information section.
How to cite this article: Hreha TN, Collins CA, 
Daugherty AL, Twentyman J, Paluri N, Hunstad DA. 
TGFβ1 orchestrates renal fibrosis following 
Escherichia coli pyelonephritis. Physiol Rep. 
2020;8:e14401. https://doi.org/10.14814/ phy2.14401
Graphical Abstract
The contents of this page will be used as part of the graphical abstract of html only. It will not be published as part of main article.
a b
c d
Circulating androgens prime the kidney for fibrosis upon infectious injury (Escherichia coli pyelonephritis) by enhancing local 
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